Preserved cellular immunity in smoldering acute leukemia.

Area of Science:

• Hematology
• Immunology

Background:

• Smoldering acute leukemia (SAL) is a variant of acute myelogenous leukemia with a typically benign clinical course.
• Its pathogenesis, particularly the reason for its indolent nature, remains poorly understood.
• Host defense mechanisms, specifically cellular immunity, are investigated to elucidate SAL's characteristics.

Purpose of the Study:

• To investigate the immunological profile of patients with smoldering acute leukemia.
• To assess cellular immunity in SAL patients and compare it to normal controls.
• To determine if preserved cellular immunity contributes to the "smoldering" nature of the disease.

Main Methods:

• Evaluation of cellular immunity in nine SAL cases.
• Inclusion of Purified Protein Derivative (PPD) skin tests (tuberculin tests) and Dinitrochlorobenzene (DNCB) sensitization tests.
• Assessment of peripheral lymphocyte blastogenesis in response to phytohemagglutinin (PHA) using smear counting.

Main Results:

• A high positive rate for PPD skin tests (88.9%) and DNCB sensitization tests (66.9%) was observed.
• The median blastoid lymphocyte ratio in SAL patients was 55%, comparable to young healthy controls (63%) and significantly higher than aged controls (41%).
• Cellular immunity in SAL patients was found to be preserved at normal levels, outperforming that of aged individuals.

Conclusions:

• Cellular immunity is preserved in patients with smoldering acute leukemia.
• This preserved immune surveillance is hypothesized to suppress the proliferation of leukemic cells, explaining the "smoldering" clinical course.
• The findings suggest a crucial role for the host's immune system in managing SAL.